Ulrich Betz

Accomplished manager with >25 years experience in the Pharmaceutical and Chemical Industry, including positions reporting directly to the Head of Research & Development at Bayer and Merck. Founder and Chairman Future Insight e.V. Proposed "Pandemic Preparedness" as topic for Merck Future Insight Prize in 2018 ! Multi-year member in the drug discovery research review boards of Merck and Bayer Convincing track record in R&D management, innovation management and drug discovery Appointed by the President of the Federal Republic of Germany as member of the German Council of Science and Humanities (Wissenschaftsrat) Member of the LOEWE Scientific Advisory Board Hessen Member of the Board of the German Chemical Society (GDCh) http://www.ulrichbetz.de Twitter: @UlrichBetz >100 publications & patents (Cell (2x), Cell Reports, Nature Medicine, Nature Biotechnology, Nature Reviews Chemistry) Author of several books for example 2024: Science and Religion United: The Salvation Machine, Springer, Hardcover ISBN 978-3-031-55093-5 Multiple Awards: International Business Awards - Stevie Gold Award - Manager of the year pharmaceuticals International Business Awards - Stevie Gold Award - Innovator of the year Edison Award German Gold Stevie Award Manager of the year German Industry Innovation Award German Idea Award BioIT World Best Practice Award Scholarship of the German National Academic Foundation Leader of the science & technology work stream for Merck's 350th anniversary in 2018. Designed and managed Curious2018 - Future Insight conference (http://curious2018.com) and Future Insight Prize Enabled dozens of innovation projects for new products with business potential of several hundred million euros in an innovation incubator at Merck Designed and implemented new "outcubation" open innovation approach and published in Nature Biotechnology Inventor and manager of the Merck Innovation Cup (http://innovationcup.merckgroup.com) Designed and rolled-out company wide innovation initiative innospire for global idea sourcing and enablement in an entrepreneurial setting, with direct sponsorship from the Merck board Post merger integration after acquisition of Serono and Millipore by Merck Designer and manager of innovation incubator innospire that led to multiple new products. Co-inventor of HCMV inhibitor Letermovir (Prevymis) which has successfully been approved by the FDA. Co-inventor of HSV inhibitor Pritelivir which has successfully passed phase II clinical trials. Dr. rer. nat. ("mit Auszeichnung") Dipl. Biochem. ("sehr gut") Abitur "1.1"